Stilla Technologies

About:

Stilla Technologies is a Paris-based european biotechnology company.

Website: https://www.stillatechnologies.com/

Twitter/X: stillatech

Top Investors: Eurazeo, European Investment Bank, Casdin Capital, Kurma Partners, Illumina Ventures

Description:

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System. Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all Life Sciences areas: research, therapeutics, and all the “omics”.

Total Funding Amount:

$102M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Villejuif, Ile-de-France, France

Founded Date:

2013-01-01

Contact Email:

info(AT)stilla.fr

Founders:

Charles Baroud, Clement Gay, Etienne Fradet, Remi Dangla

Number of Employees:

51-100

Last Funding Date:

2024-02-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai